GnRH agonist versus GnRH antagonist in ovarian stimulation: Is the emperor naked?

Clinical and Experimental Obstetrics and Gynecology

Volumn 33, Issue 4, 2006, Pages 197-199

  Orvieto, R ^a,b   Rabinson, J ^a   Meltzer, S ^a   Homburg, R ^a   Anteby, E ^a   Zohav, E ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BARZILAI MEDICAL CENTER   (Israel)

Author keywords

GnRH agonist; GnRH antagonist; IVF outcome; Pregnancy

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; PROGESTERONE;

ADULT; AMPOULE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; EMBRYO TRANSFER; ESTRADIOL BLOOD LEVEL; FEMALE; FERTILIZATION IN VITRO; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; OOCYTE; OUTCOME ASSESSMENT; OVARY HYPERSTIMULATION; PREGNANCY RATE;

ADULT; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE;

EID: 33845492346     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Ludwig M., Katalinic A., Diedrich K.: "Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis". Arch. Gynecol. Obstet., 2001, 265, 175.
2. Al-Inany H., Aboulghar M.: "GnRH antagonist in assisted reproduction: a Cochrane review". Hum. Reprod., 2002, 17, 874.
3. th International Symposium on GnRH-analogues. Cancer Hum. Reprod., 2005, A100.
4. Griesinger G., Felberbaum R., Diedrich K.: "GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German National IVF Registry". Hum. Reprod., 2005, 20, 2373.
5. Fauser B.C., Devroey P.: "Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?". Fertil. Steril., 2005, 83, 1607.
6. Hernandez E.R.: "Embryo implantation and GnRH antagonists embryo implantation: the Rubicon for GnRH antagonists". Hum. Reprod., 2000, 15, 1211.
7. Gartner B., Moreno C., Marinaro A., Remohi J., Simon C., Pellicer A.: "Accidental exposure to daily long-acting gonadotrophin-releasing hormone analogue administration and pregnancy in an in-vitro fertilisation cycle". Hum. Reprod., 1997, 12, 2557.
8. Seshagiri P.B., Terasawa E., Hern J.P.: "Secretion of gonadotrophin-releasing hormone by peri-implantation embryos of the rhesus monkey: comparison with the secretion of chorionic gonadotrophin". Hum. Reprod., 1994, 9, 1300.
9. Fujii S., Sato S., Fukui A., Kimura H., Kasai G., Saito Y.: "Continous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF". Hum. Reprod., 2001, 16, 1671.
10. Albano C., Felberbaum R.E., Smitz J., Riethmuller-Winzen H., Engel J., Diedrich K., Devroey P.: "Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group". Hum. Reprod., 2000, 15, 526.
11. European Orgalutran Study Group: "Treatment with the gonadotrophin releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial". Hum. Reprod., 2000, 15, 1490.
12. Olivennes F., Belaisch-Allart J., Emperaire J.C., Dechaud H., Alvarez S., Moreau L. et al.: "Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin)". Fertil. Steril., 2000, 73, 314.
13. European-Middle East Orgalutran Study Group: "Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of pre-mature LH surges in women undergoing ovarian stimulation". Hum. Reprod., 2001, 16, 644.
14. Fluker M., Grifo J., Leader A., Levy M., Meldrum D., Muasher S.J. et al.: "Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation". Fertil. Steril., 2001, 75, 38.
15. FIVNAT. Annual report from the French IVF registry. Bilan proviso ire 2002 (http://perso.wanadoo.fr/fivnat.fr).
16. Deutsches IVF Register. Annual report from the German IVF registry, 2003 (http://www.deutsches-ivf-register.de).
17. Orvieto R.: "Can we eliminate severe ovarian hyperstimulation syndrome?". Hum. Reprod., 2005, 20, 320.
18. Tarlatzis B.C., Zepiridis L., Grimbizis G., Bontis J.: "Clinical management of low ovarian response to stimulation for IVF: a systematic review". Hum. Reprod. Update, 2003, 9, 61.